Immunoassay for Neurological Biomarkers Market, By Disease Type (Alzheimer\'s Disease, Parkinson\'s Disease, Huntingtons Disease, Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA)), By Product, By End User, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Immunoassay for Neurological Biomarkers Market size was valued at USD 707.67 Million in 2023, expanding at a CAGR of 17.5% from 2024 to 2032.
Immunoassays for neurological biomarkers are laboratory techniques used to measure the levels of certain molecules in biological samples, such as blood or cerebrospinal fluid, that are indicative of neurological conditions or diseases. The rising prevalence of neurological disorders like Alzheimer\'s disease, Parkinson\'s disease, and multiple sclerosis creates a growing need for reliable biomarkers for early diagnosis, prognosis, and monitoring of disease progression. However, the market is facing some regulatory approval for new biomarkers and immunoassays which can be a lengthy and costly process, hindering the translation of research findings into clinically useful diagnostics. Furthermore, there is a growing emphasis on the development of biomarkers for early diagnosis and monitoring of neurological diseases, creating opportunities in future.
Immunoassay for Neurological Biomarkers Market- Market Dynamics
Ø Rising cases of neurological and psychiatric disorders
The Immunoassay for Neurological Biomarkers market plays a significant role in the detection and diagnosis of neurological and psychiatric disorders.
Immunoassays allow for the early detection of neurological biomarkers associated with various disorders such as Alzheimer\'s disease, Parkinson\'s disease, multiple sclerosis, and others. Early detection enables early intervention and treatment, potentially slowing down disease progression and improving patient outcomes. According to the World Health Organization (WHO), more than 3 billion people worldwide are living with a neurological condition due to illness & disability. In addition, over 80% of neurological deaths occur in low- and middle-income countries.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø QIAGEN
Ø Abbott
Ø Merck & Co., Inc.
Ø Johnson & Johnson Services, Inc.
Ø Thermo Fisher Scientific, Inc.
Ø Bio-Rad Laboratories, Inc.
Ø Sysmex Corporation
Ø Merck KGaA
Ø F. Hoffmann La-Roche Ltd.
Ø Nimble Therapeutics
Ø ADx NeuroSciences NV
Ø Enrolmmun
Ø ACOBIOM
Ø Banyan Biomarkers Inc.
Ø Olink Biosciences
Ø Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032
Ø Alzheimer\'s Disease
Ø Parkinson\'s Disease
Ø Huntington’s Disease
Ø Amyotrophic Lateral Sclerosis (ALS)
Ø Spinal Muscular Atrophy (SMA)
Ø Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
Ø Instruments
Ø Reagents
Ø Services
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Ø Hospitals
Ø Clinics
Ø Academic Organizations
Ø Biopharmaceutical Companies
Ø Pharmaceutical Companies
Ø Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
Ø Radioimmunoassays (RIA)
Ø Polymerase Chain Reaction (PCR)
Ø ELISA
Ø Western Blot
Ø Rapid Tests
Ø ELISPOT
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Ø North America
o The U.S.
o Canada
Ø Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Ø Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Immunoassay For Neurological Biomarkers Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Immunoassay For Neurological Biomarkers Market Snippet by Disease Type
2.1.2. Immunoassay For Neurological Biomarkers Market Snippet by Product
2.1.3. Immunoassay For Neurological Biomarkers Market Snippet by End User
2.1.4. Immunoassay For Neurological Biomarkers Market Snippet by Technology
2.1.5. Immunoassay For Neurological Biomarkers Market Snippet by Country
2.1.6. Immunoassay For Neurological Biomarkers Market Snippet by Region
2.2. Competitive Insights
3. Immunoassay For Neurological Biomarkers Key Market Trends
3.1. Immunoassay For Neurological Biomarkers Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Immunoassay For Neurological Biomarkers Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Immunoassay For Neurological Biomarkers Market Opportunities
3.4. Immunoassay For Neurological Biomarkers Market Future Trends
4. Immunoassay For Neurological Biomarkers Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Immunoassay For Neurological Biomarkers Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Immunoassay For Neurological Biomarkers Market Landscape
6.1. Immunoassay For Neurological Biomarkers Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Immunoassay For Neurological Biomarkers Market – By Disease Type
7.1. Overview
7.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
7.1.2. Alzheimer\'s Disease
7.1.3. Parkinson\'s Disease
7.1.4. Huntington’s Disease
7.1.5. Amyotrophic Lateral Sclerosis (ALS)
7.1.6. Spinal Muscular Atrophy (SMA)
7.1.7. Others
8. Immunoassay For Neurological Biomarkers Market – By Product
8.1. Overview
8.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
8.1.2. Instruments
8.1.3. Reagents
8.1.4. Services
9. Immunoassay For Neurological Biomarkers Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
9.1.2. Hospitals
9.1.3. Clinics
9.1.4. Academic Organizations
9.1.5. Biopharmaceutical Companies
9.1.6. Pharmaceutical Companies
9.1.7. Others
10. Immunoassay For Neurological Biomarkers Market – By Technology
10.1. Overview
10.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
10.1.2. Radioimmunoassays (RIA)
10.1.3. Polymerase Chain Reaction (PCR)
10.1.4. ELISA
10.1.5. Western Blot
10.1.6. Rapid Tests
10.1.7. ELISPOT
11. Immunoassay For Neurological Biomarkers Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Immunoassay For Neurological Biomarkers Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Immunoassay For Neurological Biomarkers Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Immunoassay For Neurological Biomarkers Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Immunoassay For Neurological Biomarkers Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Immunoassay For Neurological Biomarkers Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Immunoassay For Neurological Biomarkers Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. QIAGEN
12.2.2. Abbott
12.2.3. Merck & Co., Inc.
12.2.4. Johnson & Johnson Services, Inc.
12.2.5. Thermo Fisher Scientific, Inc.
12.2.6. Bio-Rad Laboratories, Inc.
12.2.7. Sysmex Corporation
12.2.8. Merck KGaA
12.2.9. F. Hoffmann La-Roche Ltd.
12.2.10. Nimble Therapeutics
12.2.11. ADx NeuroSciences NV
12.2.12. Enrolmmun
12.2.13. ACOBIOM
12.2.14. Banyan Biomarkers Inc.
12.2.15. Olink Biosciences
12.2.16. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
